Will New Trial Solution Data Spark a Rally for this Dual-Listed Gen AI Clinical Trial Leader?
29 Febbraio 2024 - 4:00PM
AllPennyStocks.com
Parkinson’s disease is a complex and debilitating disease with a
need for novel treatment options. This firm’s goal is to advance
its understanding of the biological markers and...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni NetraMark (CSE:AIAI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni NetraMark (CSE:AIAI)
Storico
Da Giu 2023 a Giu 2024